| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
20,445 |
19,372 |
$3.86M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,173 |
12,434 |
$3.52M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,273 |
17,260 |
$2.55M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,232 |
3,108 |
$1.12M |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,460 |
7,295 |
$1.02M |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
4,548 |
775 |
$697K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,451 |
2,365 |
$439K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,712 |
6,645 |
$432K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,233 |
2,192 |
$329K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,427 |
6,674 |
$295K |
| D2934 |
|
1,808 |
413 |
$286K |
| 87631 |
|
1,968 |
1,937 |
$268K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,069 |
2,547 |
$249K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,897 |
4,298 |
$245K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,595 |
4,190 |
$216K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,118 |
2,069 |
$213K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,387 |
4,554 |
$205K |
| 71046 |
Radiologic examination, chest; 2 views |
3,538 |
3,432 |
$204K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,994 |
23,007 |
$201K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,930 |
1,596 |
$199K |
| 80053 |
Comprehensive metabolic panel |
14,737 |
13,849 |
$194K |
| 71045 |
Radiologic examination, chest; single view |
3,208 |
3,029 |
$172K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,174 |
3,549 |
$154K |
| D7140 |
Extraction, erupted tooth or exposed root |
958 |
328 |
$150K |
| G0378 |
Hospital observation service, per hour |
289 |
280 |
$147K |
| 93976 |
|
932 |
901 |
$138K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,237 |
1,072 |
$137K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,268 |
1,244 |
$127K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
10,539 |
9,662 |
$117K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,319 |
3,256 |
$115K |
| 0225U |
|
265 |
265 |
$112K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,322 |
3,259 |
$112K |
| 73562 |
|
1,037 |
888 |
$95K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
264 |
262 |
$90K |
| 81513 |
|
772 |
754 |
$88K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
376 |
372 |
$80K |
| 84484 |
|
4,778 |
4,068 |
$77K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,904 |
2,389 |
$76K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,699 |
4,618 |
$75K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
772 |
761 |
$74K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
329 |
316 |
$70K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
646 |
636 |
$68K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
609 |
597 |
$68K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
419 |
136 |
$67K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
941 |
867 |
$64K |
| 76830 |
Ultrasound, transvaginal |
559 |
549 |
$63K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
437 |
435 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,222 |
1,197 |
$60K |
| 73610 |
|
587 |
543 |
$60K |
| 80076 |
|
5,500 |
5,240 |
$58K |
| 83690 |
|
7,067 |
6,604 |
$55K |
| D0210 |
Intraoral - complete series of radiographic images |
237 |
234 |
$55K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,827 |
966 |
$52K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,301 |
1,251 |
$50K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,153 |
5,838 |
$49K |
| D1206 |
Topical application of fluoride varnish |
292 |
291 |
$48K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,342 |
4,124 |
$48K |
| 73030 |
|
519 |
468 |
$47K |
| 36415 |
Collection of venous blood by venipuncture |
9,032 |
8,456 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,329 |
2,282 |
$40K |
| 81025 |
|
3,764 |
3,624 |
$38K |
| 96376 |
|
1,272 |
985 |
$36K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,470 |
1,461 |
$34K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,081 |
697 |
$33K |
| 73110 |
|
445 |
396 |
$33K |
| 81001 |
|
7,025 |
6,668 |
$33K |
| 84702 |
|
1,830 |
1,563 |
$32K |
| 59025 |
Fetal non-stress test |
257 |
213 |
$31K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,648 |
3,602 |
$31K |
| 85027 |
|
4,827 |
4,564 |
$31K |
| 83735 |
|
4,330 |
3,969 |
$31K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
816 |
799 |
$30K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
763 |
759 |
$29K |
| 73130 |
|
371 |
331 |
$28K |
| 87481 |
|
826 |
805 |
$28K |
| 86780 |
|
2,160 |
2,139 |
$28K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
435 |
421 |
$28K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
830 |
811 |
$28K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,017 |
1,012 |
$27K |
| 83605 |
|
3,040 |
2,685 |
$27K |
| J3490 |
Unclassified drugs |
15,850 |
5,629 |
$26K |
| 83880 |
|
1,175 |
1,114 |
$26K |
| 86803 |
|
1,850 |
1,840 |
$25K |
| 73630 |
|
351 |
336 |
$24K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
196 |
181 |
$22K |
| 87650 |
|
985 |
971 |
$21K |
| 84439 |
|
2,342 |
2,303 |
$21K |
| 82077 |
|
1,803 |
1,657 |
$20K |
| 84703 |
|
1,820 |
1,759 |
$20K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
749 |
743 |
$19K |
| 97162 |
|
372 |
368 |
$19K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
246 |
234 |
$19K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
556 |
555 |
$18K |
| 80061 |
Lipid panel |
1,402 |
1,391 |
$18K |
| 81514 |
|
95 |
95 |
$18K |
| 87077 |
|
2,128 |
2,039 |
$18K |
| 86850 |
|
1,811 |
1,738 |
$18K |
| 81003 |
|
4,819 |
4,619 |
$17K |
| 85379 |
|
1,085 |
1,050 |
$17K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
283 |
277 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
200 |
199 |
$16K |
| 73502 |
|
319 |
297 |
$16K |
| 87653 |
|
433 |
427 |
$15K |
| D1120 |
Prophylaxis - child |
90 |
90 |
$15K |
| 87634 |
|
224 |
223 |
$15K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
27 |
27 |
$15K |
| 82075 |
|
589 |
526 |
$14K |
| 87186 |
|
1,392 |
1,332 |
$14K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
50 |
50 |
$14K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
427 |
250 |
$13K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
81 |
80 |
$13K |
| 87081 |
|
1,790 |
1,774 |
$13K |
| 87040 |
|
808 |
610 |
$12K |
| 76801 |
|
97 |
91 |
$12K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
6,101 |
5,083 |
$11K |
| 85610 |
|
2,420 |
2,239 |
$11K |
| 86900 |
|
2,170 |
2,063 |
$11K |
| 94010 |
|
82 |
78 |
$11K |
| 82962 |
|
2,033 |
1,404 |
$11K |
| J2704 |
Injection, propofol, 10 mg |
3,063 |
2,798 |
$10K |
| 72100 |
|
105 |
105 |
$9K |
| 86901 |
|
2,167 |
2,061 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
363 |
352 |
$9K |
| 86762 |
|
608 |
605 |
$9K |
| 87340 |
|
852 |
846 |
$9K |
| 86787 |
|
631 |
628 |
$8K |
| 82805 |
|
147 |
132 |
$8K |
| 82728 |
|
593 |
584 |
$8K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
140 |
102 |
$8K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
15 |
15 |
$8K |
| D3221 |
|
357 |
117 |
$7K |
| 99201 |
|
190 |
182 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,068 |
4,704 |
$7K |
| 86140 |
|
1,647 |
1,559 |
$7K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,171 |
1,747 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
252 |
249 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
146 |
144 |
$6K |
| 87660 |
|
281 |
278 |
$6K |
| 87510 |
|
281 |
278 |
$6K |
| 87480 |
|
282 |
279 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,163 |
5,445 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
14 |
14 |
$5K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
4,525 |
3,409 |
$5K |
| 85652 |
|
1,021 |
987 |
$5K |
| D3330 |
Endodontic therapy, molar tooth (excluding final restoration) |
35 |
12 |
$5K |
| 70486 |
|
29 |
27 |
$5K |
| 36000 |
|
639 |
625 |
$4K |
| 93971 |
|
52 |
50 |
$4K |
| 74018 |
|
60 |
60 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
53 |
49 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
902 |
744 |
$4K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
26 |
26 |
$4K |
| 73080 |
|
56 |
52 |
$4K |
| 94729 |
|
66 |
65 |
$4K |
| 94726 |
|
27 |
26 |
$4K |
| 82570 |
|
729 |
682 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,927 |
2,830 |
$3K |
| 97161 |
|
119 |
117 |
$3K |
| 94760 |
|
661 |
540 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,263 |
1,974 |
$3K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
47 |
30 |
$3K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
129 |
129 |
$3K |
| 83655 |
|
202 |
201 |
$3K |
| 82550 |
|
314 |
290 |
$2K |
| 90715 |
|
251 |
249 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
31 |
31 |
$2K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
202 |
197 |
$2K |
| 88304 |
|
59 |
59 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16 |
15 |
$2K |
| 82950 |
|
266 |
265 |
$2K |
| 80074 |
|
24 |
24 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
866 |
722 |
$1K |
| 82043 |
|
224 |
220 |
$1K |
| 83550 |
|
103 |
97 |
$1K |
| 82607 |
|
65 |
64 |
$1K |
| 80179 |
|
57 |
54 |
$923.44 |
| 94762 |
|
19 |
13 |
$901.25 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
619 |
569 |
$892.59 |
| 83540 |
|
116 |
110 |
$885.99 |
| J2060 |
Injection, lorazepam, 2 mg |
606 |
518 |
$820.90 |
| 80143 |
|
46 |
43 |
$756.37 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
892 |
859 |
$698.97 |
| 94375 |
|
13 |
12 |
$634.20 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
551 |
438 |
$605.30 |
| 82140 |
|
42 |
39 |
$597.69 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
66 |
39 |
$562.58 |
| 87210 |
|
97 |
94 |
$541.92 |
| 84145 |
|
18 |
18 |
$495.43 |
| 81002 |
|
172 |
167 |
$479.16 |
| 82565 |
|
78 |
76 |
$385.12 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
86 |
76 |
$314.32 |
| 83615 |
|
41 |
40 |
$291.99 |
| 84156 |
|
76 |
68 |
$289.29 |
| 97016 |
|
26 |
14 |
$284.90 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
497 |
456 |
$266.78 |
| 85730 |
|
53 |
53 |
$261.66 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
14 |
13 |
$260.57 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
26 |
12 |
$249.89 |
| 84550 |
|
44 |
41 |
$212.28 |
| S0028 |
Injection, famotidine, 20 mg |
100 |
84 |
$201.64 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
34 |
26 |
$193.21 |
| 82248 |
|
31 |
31 |
$173.45 |
| 85018 |
|
61 |
60 |
$160.51 |
| 85014 |
|
54 |
52 |
$160.35 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
31 |
29 |
$139.22 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
73 |
69 |
$131.75 |
| J1815 |
Injection, insulin, per 5 units |
67 |
29 |
$122.86 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
33 |
28 |
$104.08 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
41 |
40 |
$102.06 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
18 |
14 |
$90.69 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
63 |
61 |
$85.85 |
| 82247 |
|
15 |
15 |
$84.39 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
125 |
72 |
$68.41 |
| 82040 |
|
12 |
12 |
$65.32 |
| 84460 |
|
12 |
12 |
$62.71 |
| 84450 |
|
12 |
12 |
$61.35 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
129 |
124 |
$58.32 |
| G0008 |
Administration of influenza virus vaccine |
25 |
25 |
$53.80 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
14 |
$50.71 |
| 88738 |
|
12 |
12 |
$49.95 |
| J1790 |
Injection, droperidol, up to 5 mg |
31 |
28 |
$49.46 |
| 84520 |
|
12 |
12 |
$43.23 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
67 |
60 |
$31.86 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
13 |
13 |
$21.96 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
29 |
29 |
$15.06 |
| J1630 |
Injection, haloperidol, up to 5 mg |
15 |
14 |
$14.49 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
60 |
55 |
$12.58 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
15 |
12 |
$11.15 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
14 |
12 |
$4.97 |